BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33629833)

  • 21. Performance and usefulness of a novel automated immunoassay HISCL SARS-CoV-2 Antigen assay kit for the diagnosis of COVID-19.
    Saito K; Ai T; Kawai A; Matsui J; Fukushima Y; Kikukawa N; Kyoutou T; Chonan M; Kawakami T; Hosaka Y; Misawa S; Takagi H; Matsushita Y; Hiki M; Okuzawa A; Hori S; Naito T; Miida T; Takahashi K; Tabe Y
    Sci Rep; 2021 Dec; 11(1):23196. PubMed ID: 34853366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platinum-Decorated Gold Nanoparticle-Based Microfluidic Chip Immunoassay for Ultrasensitive Colorimetric Detection of SARS-CoV-2 Nucleocapsid Protein.
    Wu F; Mao M; Cai L; Lin Q; Guan X; Shi X; Ma L
    ACS Biomater Sci Eng; 2022 Sep; 8(9):3924-3932. PubMed ID: 35929757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 variants' cross-reactivity on the paper microfluidic particle counting immunoassay.
    Kim S; Eades C; Yoon JY
    Anal Bioanal Chem; 2022 Nov; 414(28):7957-7965. PubMed ID: 36131142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal Assessment of SARS-CoV-2 Antinucleocapsid and Antispike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection.
    El-Khoury JM; Schulz WL; Durant TJS
    J Appl Lab Med; 2021 Jul; 6(4):1005-1011. PubMed ID: 33822964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels.
    Ray P; Ledgerwood-Lee M; Brickner H; Clark AE; Garretson A; Graham R; Van Zant W; Carlin AF; Aronoff-Spencer ES
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Label-Free Electrochemical Impedimetric Immunosensor with Biotinylated-Antibody for SARS-CoV-2 Nucleoprotein Detection in Saliva.
    Wu CC; Chiang YH; Chiang HY
    Biosensors (Basel); 2022 Apr; 12(5):. PubMed ID: 35624566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay.
    Grant BD; Anderson CE; Alonzo LF; Garing SH; Williford JR; Baughman TA; Rivera R; Glukhova VA; Boyle DS; Dewan PK; Weigl BH; Nichols KP
    PLoS One; 2021; 16(11):e0258819. PubMed ID: 34758052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
    Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device.
    Nishimura K; Kitazawa H; Kawahata T; Yuhara K; Masuya T; Kuroita T; Waki K; Koike S; Isobe M; Kurosawa N
    BMC Immunol; 2023 Sep; 24(1):34. PubMed ID: 37752417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasensitive and Simultaneous Detection of Two Specific SARS-CoV-2 Antigens in Human Specimens Using Direct/Enrichment Dual-Mode Fluorescence Lateral Flow Immunoassay.
    Wang C; Cheng X; Liu L; Zhang X; Yang X; Zheng S; Rong Z; Wang S
    ACS Appl Mater Interfaces; 2021 Sep; 13(34):40342-40353. PubMed ID: 34412466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrochemical immunosensor with Cu
    Rahmati Z; Roushani M; Hosseini H; Choobin H
    Mikrochim Acta; 2021 Mar; 188(3):105. PubMed ID: 33651173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying SARS-CoV-2 nucleocapsid antigen in oropharyngeal swabs using single molecule array technology.
    Olsen DA; Brasen CL; Kahns S; Madsen JB; Kierkegaard H; Christensen H; Jensen A; Sydenham TV; Møller JK; Madsen JS; Brandslund I
    Sci Rep; 2021 Oct; 11(1):20323. PubMed ID: 34645907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests.
    Yamaoka Y; Miyakawa K; Jeremiah SS; Funabashi R; Okudela K; Kikuchi S; Katada J; Wada A; Takei T; Nishi M; Shimizu K; Ozawa H; Usuku S; Kawakami C; Tanaka N; Morita T; Hayashi H; Mitsui H; Suzuki K; Aizawa D; Yoshimura Y; Miyazaki T; Yamazaki E; Suzuki T; Kimura H; Shimizu H; Okabe N; Hasegawa H; Ryo A
    Cell Rep Med; 2021 Jun; 2(6):100311. PubMed ID: 34027498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic Bead-Based Immunoassay Allows Rapid, Inexpensive, and Quantitative Detection of Human SARS-CoV-2 Antibodies.
    Huergo LF; Selim KA; Conzentino MS; Gerhardt ECM; Santos ARS; Wagner B; Alford JT; Deobald N; Pedrosa FO; de Souza EM; Nogueira MB; Raboni SM; Souto D; Rego FGM; Zanette DL; Aoki MN; Nardin JM; Fornazari B; Morales HMP; Borges VA; Nelde A; Walz JS; Becker M; Schneiderhan-Marra N; Rothbauer U; Reis RA; Forchhammer K
    ACS Sens; 2021 Mar; 6(3):703-708. PubMed ID: 33496577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody.
    Terry JS; Anderson LB; Scherman MS; McAlister CE; Perera R; Schountz T; Geiss BJ
    Virology; 2021 Jun; 558():28-37. PubMed ID: 33714753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection.
    Ahava MJ; Kurkela S; Kuivanen S; Lappalainen M; Jarva H; Jääskeläinen AJ
    J Virol Methods; 2022 Apr; 302():114469. PubMed ID: 35051445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals.
    Berg MG; Israeli E; Quaco E; Cloherty GA; Hemken PM
    Biotechniques; 2021 Jul; 71(1):370-375. PubMed ID: 34139879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorimetric and Raman dual-mode lateral flow immunoassay detection of SARS-CoV-2 N protein antibody based on Ag nanoparticles with ultrathin Au shell assembled onto Fe
    Li J; Liang P; Zhao T; Guo G; Zhu J; Wen C; Zeng J
    Anal Bioanal Chem; 2023 Feb; 415(4):545-554. PubMed ID: 36414739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA.
    Kasetsirikul S; Umer M; Soda N; Sreejith KR; Shiddiky MJA; Nguyen NT
    Analyst; 2020 Nov; 145(23):7680-7686. PubMed ID: 32975254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.